Industry Impact of Supreme Court Gene-Patent Ruling

Industry Impact of Supreme Court Gene-Patent Ruling Play

June 13 (Bloomberg) -- The U.S. Supreme Court restricted the ability of companies to patent human genetic sequences, issuing a mixed ruling in a case that raised questions about thousands of biotechnology, agricultural and drug patents. Greg Stohr reports on Bloomberg Television's "Bottom Line." (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus